Tag: drug development
June 10, 2018
5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top
MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 17, 2018
Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial
Aside from the recent funding and Phase 3 trial news, Resverlogix has many milestones for investors to look forward to...
May 9, 2018
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and... May 7, 2018
Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.
Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has... May 4, 2018
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...
May 2, 2018
Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease
Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued... May 1, 2018